GPT and sarcoma: Regarding the clinical outcome of TMM, TA or subunit transcript expressions are generally associated with poor prognosis in breast, colorectal and lung cancer [68], but for patients with ALT, the prognosis varies among different tumor types of sarcoma and astrocytoma, where ALT shows high prevalence.